|
|
|
|
||
|
||
|
Vol. 8, Nos. 1-50, pp. 1-1650 Jan. 1 -- Dec. 31, 2010 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Safeway Inc. v. Abbott Labs. (N.D. Cal.), 126
Salix Pharms. Ltd. v. Novel Labs. Inc. (D.N.J.), 1144 Saltzman v. Independence Blue Cross (3d Cir.), 779 Sanchez v. Wal-Mart Stores Inc. (Nev.), 89 Sandler, U.S. ex rel. v. Wyeth (E.D. Pa.), 715; 1209; 1342 Sandoz Inc.; Allergan Inc. v. (E.D. Tex.), 35 Sandoz Inc.; Bayer Schera Pharma AG v. (S.D.N.Y.), 1136; 1270 Sandoz Inc.; Bayer Schering Pharma AG v. (S.D.N.Y.), 456 Sandoz Inc. v. Boehringer Ingelheim Intl. GmbH (M.D. Fla.), 1020 Sandoz Inc.; Dorsett v. (C.D. Cal.), 455 Sandoz Inc.; Duramed Pharms. Inc. v. (D.N.J.), 623 Sandoz Inc.; Endo Pharms. Inc. v. (D.N.J.), 746 Sandoz Inc.; Genzyme Corp. v. (D. Del.), 682 Sandoz Inc.; King Pharms. Inc. v. (D.N.J.), 641; 676 Sandoz Inc.; Novo Nordisk Inc. v. (S.D.N.Y.), 1616 Sandoz Inc.; Otsuka Pharm. Co. v. (D.N.J.), 1458 Sandoz Inc.; Pfizer Inc. v. (D. Colo.), 205 Sandoz Inc.; Sanofi-Aventis U.S. LLC v. (D.N.J.), 273; 384; 552 Sandoz Inc.; Teva Pharms. USA Inc. v. (S.D.N.Y.), 1212 Sanofi-Aventis Deutschland GMBH v. Glenmark Pharms. Inc. (D.N.J.), 775 Sanofi-Aventis U.S. LLC; Eisai Inc. v. (D.N.J.), 1083; 1213 Sanofi-Aventis U.S. LLC v. FDA (D.D.C.), 975; 1018; 1138 Sanofi-Aventis U.S. LLC v. Sandoz Inc. (D.N.J.), 273; 384; 552 Sanofi-Synthelabo v. Apotex Inc. (S.D.N.Y.), 514; 1339 Santa Clara, County of v. Astra USA Inc. (9th Cir.), 34; (U.S., rev grant), 1243; (amicus brief filed), 1618 Santa Clara, County of v. SmithKlineBeecham Corp. (N.D. Cal.), 355 SB Pharmco P.R. Inc.; U.S. v. (D. Mass.), 1363 Schedin v. Johnson & Johnson (D. Minn.), 1505; 1582 Schering Corp. v. Impax Labs. Inc. (D.N.J.), 1107 Schering-Plough Corp. v. Glenmark Pharms. Inc. (D.N.J.), 553; 622 Schering-Plough Corp. v. Mylan Pharms. Inc. (D.N.J.), 7; 780 Schering-Plough Corp. ERISA Litig., In re (3d Cir.), 14 Schering-Plough Corp. ERISA Litig., In re (D.N.J.), 891 Schering-Plough Corp. Sec. Litig., In re (D.N.J.), 39 Schiff; U.S. v. (3d Cir.), 491 Schilf v. Eli Lilly & Co. (D.S.D.), 1310; 1364 Schindler Elevator Corp. v. U.S. ex rel. Kirk (U.S., brief filed), 1551 Schwarzenegger; National Ass'n of Chain Drug Stores v. (C.D. Cal.), 484; (9th Cir.), 515 Schwarz Pharma; U.S. ex rel. Conrad v. (D. Mass.), 585 Schwarz Pharma; U.S. ex rel. Conrad v. (S.D. Tex.), 585 Scroggin; Wyeth v. (U.S., brief filed), 718; (rev den), 816 Sebelius; Action Alliance of Senior Citizens v. (D.C. Cir.), 815 Sebelius; Apotex Inc. v. (D.D.C.), 414; (D.C. Cir.), 451; 644; 885; (U.S., rev sought), 1301 Sebelius; Cody Labs. Inc. v. (D. Wyo.), 980; 1500 Sebelius; Friedman v. (D.D.C.), 161; 1575 Sebelius; Graceway Pharms. LLC v. (D.D.C.), 945 Sebelius; Hays v. (D.C. Cir.), 9 Sebelius; Teva Pharms. USA Inc. v. (D.C. Cir.), 267; 312; 644; (D.D.C.), 349; 415 Sebelius; Winston Labs Inc. v. (N.D. Ill.), 183 SEC v. Benhamou (S.D.N.Y.), 1401 SEC v. Biovail Corp. (S.D.N.Y.), 817 SEC v. Self (E.D. Pa.), 1148 SEC v. Wagner (D. Mass.), 92 Securities and Exchange Comm'n Self; SEC v. (E.D. Pa.), 1148 Senju Pharm. Co. v. Apotex Inc. (D. Del.), 851 Sepracor Inc. v. Barr Pharms. (E.D.N.C.), 1617 Sepracor Inc. v. Dey LP (D. Del.), 945 Sepracor Inc. v. Teva Pharms. USA Inc. (D.N.J.), 774; 1054 Sheet Metal Workers, Local 441 Health & Welfare Plan v. GlaxoSmithKline PLC (E.D. Pa.), 1215; 1305; 1431 Shionogi Pharma Inc. v. Mylan Inc. (D. Del.), 1620 Shire Dev. Inc. v. Cadila Healthcare Ltd. (D. Del.), 947 Shire LLC v. Nostrum Pharms. Inc. (D.N.J.), 386 Shire US Inc.; Hunter v. (Pa. Super. Ct.), 418 Shurtleff v. GlaxoSmithKline LLC (Utah Dist. Ct.), 1466 Shurtleff v. Janssen-Ortho Inc. (Utah Dist. Ct.), 623 Sicor Pharms. Inc.; Eli Lilly & Co. v. (S.D. Ind.), 453 Simon v. Wyeth Pharms. Inc. (Pa. Super. Ct.), 64 Singleton v. Wyeth (Pa. Ct. Com. Pl.), 278 Siracusano; Matrixx Initiatives Inc. v. (U.S., rev grant), 856; (amicus brief filed), 1143; 1470 Smith v. Bayer Corp. (U.S., rev grant), 1273 Smith v. Pfizer Inc. (M.D. Tenn.), 322; 627; 682 Smith v. SmithKlineBeecham Corp. (E.D. Ky.), 1185 Smith v. Wyeth Inc. (6th Cir.), 916; 1501 SmithKlineBeecham Corp.; Aaron v. (S.D. Ill.), 626 SmithKlineBeecham Corp.; American Sales Co. v. (E.D. Pa.), 1464 SmithKlineBeecham Corp.; Dietz v. (11th Cir.), 319 SmithKlineBeecham Corp. v. Glenmark Generics Inc. (D. Del.), 485 SmithKlineBeecham Corp.; Hayes v. (N.D. Okla.), 10 SmithKlineBeecham Corp.; Mason v. (7th Cir.), 271 SmithKlineBeecham Corp.; Miller v. (10th Cir.), 744 SmithKlineBeecham Corp.; Mylan Inc. v. (D.N.J.), 1340; 1395 SmithKlineBeecham Corp.; Pettit v. (S.D. Ohio), 522 SmithKlineBeecham Corp.; Roxane Labs. Inc. v. (E.D. Pa.), 153 SmithKlineBeecham Corp.; Santa Clara, County of v. (N.D. Cal.), 355 SmithKlineBeecham Corp.; Smith v. (E.D. Ky.), 1185 SmithKlineBeecham Corp.; Tucker v. (S.D. Ind.), 490 SmithKlineBeecham Corp.; Vanderwerf v. (10th Cir.), 587; 648 SmithKlineBeecham Corp.; Wells v. (5th Cir.), 386 Solvay Pharms. Inc.; U.S. ex rel. Hopper v. (U.S., rev den), 815 Solvay S.A.; U.S. ex rel. King v. (S.D. Tex.), 982 Sorrell; IMS Health Inc. v. (2d Cir.), 1496; (U.S., rev sought), 1614 Spivack, U.S. ex rel. v. Johnson & Johnson (D. Mass.), 585 Stanger v. APP Pharms. LLC (D.N.J.), 1556 Stanley v. Mylan Inc. (D. Utah), 1248 State v.
See specific state
Subpoenas, In re (W.D. Va.), 518 Sun Pharma Global Inc.; Orion Corp. v. (D.N.J.), 813 Sun Pharm. Indus. Ltd. v. Eli Lilly & Co. (Fed. Cir.), 1013; 1393 Sun Pharm. Indus. Ltd.; Orion Corp. v. (D.N.J.), 813 Sun Pharm. Indus. Ltd.; Wyeth v. (E.D. Mich.), 313 Supervalu Inc. v. Unimed Pharms. LLC (N.D. Ga.), 486 Swicegood v. Pliva Inc. (N.D. Ga.), 420 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
